Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Operating Income (2025 - 2026)

Updated

Polaryx Therapeutics' Operating Income was -$1.38 million in Q2 2026, compared with -$884,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Operating Income (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Polaryx Therapeutics' Operating Income was -$9.27 million through Jun 30, 2026; for FY2025, it was -$7.82 million.

  • In earlier years, Operating Income was -$4.35 million in FY2024.
  • Quarterly Operating Income has moved between -$5.05 million (Q1 2025) and -$884,000 (Q2 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 7.14 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.43 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 3.16 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.39 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.27 Bn
10 Polaryx Therapeutics 103.68 Mn 79.29 Mn - -1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 -1.96 Mn
Jun 30, 2025 -884,000.00
Mar 31, 2025 -5.05 Mn
API Access

Polaryx Therapeutics Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=PLYX&period=max&api_key=YOUR_API_KEY